The Assay couples the advantages of real-time PCR technology with a streamlined environmental sampling protocol, providing rapid and accurate results with superior specificity.
Asia
Europe, Middle East, Africa
North America
bioMérieux, Inc. Receives Nine AOAC Approvals in November
07 December, 2020
These approvals add to bioMérieux’s already vast AOAC approved portfolio across their pathogen and quality indicator suite of solutions, and demonstrates a long-standing commitment to robust, sound, and validated science.
bioMérieux Announces CLARION™ Infectious Diseases and Diagnostics Software
19 November, 2020
The innovative software-as-a-service reflects growing capabilities and global mission for antimicrobial stewardship and surveillance.
Holiday Shipping Schedule
17 November, 2020
Please be advised that in observance of upcoming holidays, bioMérieux, Inc. sites in Durham, NC, St. Louis, MO, Louisville, KY, and Lombard, IL will be closed on: Thursday/Friday November 26/27, 2020 Thursday/Friday December 24/25, 2020 Friday January 1, 2021 We encourage you to place orders with the following dates in mind.
bioMérieux launches Predictive Diagnostics, pairing microbiology solutions with data science, sequencing and predictive modeling
26 October, 2020
Predictive Diagnostics uses traditional core microbiology solutions alongside data science, sequencing applications and predictive modeling to help move food producers from being reactive to being proactive.
10 Organizations Across U.S. Receive Over €3 Million From bioMérieux
12 October, 2020
Due to the significant economic and social consequences presented by the COVID-19 pandemic, bioMérieux has decided to distribute 50% of its 2019 dividend as corporate philanthropy to support charitable initiatives around the world.
Mérieux NutriSciences EnviroMap Collaborates with bioMérieux, Inc.
04 September, 2020
Mérieux NutriSciences collaborates with bioMérieux, Inc. to deliver EnviroMap® to the food industry.
bioMérieux Receives Emergency Use Authorization for Its VIDAS® SARS-CoV-2 Antibody Serology Tests
07 August, 2020
bioMérieux has received Emergency Use Authorization by the U.S. Food and Drug Administration of its VIDAS® SARS-COV-2 IgM and VIDAS® SARS-COV-2 IgG serology tests.
bioMérieux Continues to Win Numerous Industry Awards for Outstanding Service and Performance
21 July, 2020
bioMérieux has recently been recognized with six IMV ServiceTrak™ Clinical awards for Blood Culture and ID/AST excellence.
Launch of BIOFIRE® MYCOPLASMA test for mycoplasma detection in biopharmaceutical products
16 July, 2020
bioMérieux announces the launch of BIOFIRE® MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biotherapeutics (antibodies, hormones, cell and gene therapies, etc.), the most vibrant sector in the pharmaceutical industry.